ArticleBMC primary care2025
The dual impact of social prescribing: targeting social determinants to enhance quality of life in chronic conditions.
Article in BMC primary care, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Changes in mental health during participation in Art Pharmacy: a longitudinal study of a U.S. arts-based social prescribing program.Frontiers in public health · 2026Article
- Connecting for health: qualitative exploration of community nursing in social prescribing for social determinants of health.Frontiers in public health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundChronic diseases are heavily influenced by social determinants of health (SDoH), requiring care that extends beyond medical interventions to address underlying issues. Social prescribing, which connects individuals to community resources, offers holistic care complementary to health systems. However, social prescribing requires context-specific tailoring and ongoing evaluation to meet community needs.
aimTo evaluate a 12-week social prescribing intervention targeting SDoH for individuals with, or at risk of developing chronic disease on health-related quality of life, general wellbeing, mental wellbeing, self-reported health, and healthcare utilisation. A secondary aim was to assess participant satisfaction with social prescribing.
methodsA pre-post design using de-identified data collected from an ongoing intervention. Eligibility included adults in south-east New South Wales who presented to their General Practitioner (GP) with, or at risk of, chronic disease and completed the intervention between July 1, 2022, and June 30, 2024. The social prescribing model involved link workers and participants co-designing individualised plans based on their needs and interests, conducted either in-person or by telephone consultations. Outcome measures collected pre- and post-intervention included health-related quality of life, self-reported health, general wellbeing, mental wellbeing, and healthcare utilisation.
resultsThe study included 281 participants (mean age 57.7 years, 66.6% female). Significant improvements were observed in health-related quality of life (p < 0.001, Cohen's d = 0.645), self-reported health (p < 0.001, Cohen's d = 0.709), general wellbeing (p < 0.001, Cohen's d = 0.438), and mental wellbeing (p < 0.001, Cohen's d = 0.723). These benefits were consistent across binary gender and age groups. A non-significant trend toward reduced healthcare utilisation was observed. Participants reported high satisfaction with the program (9.27/10), with 75% stating they would not change it and a high likelihood (9.53/10) of recommending it to others.
conclusionsSocial prescribing addressing SDoH improved health-related quality of life, wellbeing, and self-reported health for adults with, or at risk of developing, chronic diseases. This study is the first Australian evaluation of social prescribing demonstrating benefits on general wellbeing and mental wellbeing, with future analysis planned to explore impacts among Australia's specific cultural and linguistic groups.
trial registrationN/A.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.